在急性不补偿性心力衰竭中使用乙胺的功能和脱血:ADVOR试验
Evelyne Meekers1,2, Jeroen Dauw2,3, Pieter Martens1,4
1Department of Cardiology, Ziekenhuis Oost-Limburg AV, Schiepse Bos 6, 3600 Genk, Belgium.
European heart journal
|August 25, 2023
概括
乙胺有效地改善了所有功能水平的急性不补偿性心力衰竭 (ADHF) 的脱血. 虽然功能恶化 (WRF) 更常见,但它不会导致更糟糕的临床结果.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性不补偿性心力衰竭 (ADHF) 提出了重大的临床挑战.
- 尿剂耐药性在ADHF中很常见,需要使用替代治疗策略.
- 乙胺在ADHF中的作用,特别是关于功能,需要进一步阐明.
研究的目的:
- 评估乙醇胺在促进ADHF患者在功能全方位的患者的脱血中的疗效.
- 评估乙醇胺对利尿症,自然利尿症和功能的影响.
- 确定乙醇胺治疗,恶化功能和临床结果之间的关联.
主要方法:
- 预先规定的ADVOR试验分析,涉及519名ADHF患者,随机分配给乙胺或安慰剂.
- 根据基线功能 (eGFR) 分层的脱血,尿液,自然尿液和临床结果的评估.
- 在治疗手臂之间评估功能变化和恶化功能 (WRF) 的发生率.
主要成果:
- 无论基线估计的淋巴细胞过率 (eGFR) 是如何,阿西塔佐拉米德始终提高了脱血.
- 与乙醇胺一起观察到更高的自然尿和利尿,在具有较低EGFR的患者中效果更大.
- 乙胺增加了WRF的发生率,但这与3个月后的不良临床结果或长期死亡率/住院病例无关.
结论:
- 乙胺在所有功能水平的ADHF患者的脱血中是有效的.
- 乙醇胺的尿和利尿作用在功能受损的患者中更为明显.
- 尽管WRF的发病率较高,但在ADHF中使用乙胺治疗似乎不会恶化长期的临床结果.
相关概念视频
01:22Heart Failure Drugs: Diuretics
420
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
420
01:30Heart Failure V: Medical Management
13
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
01:20Acute Kidney Injury V: Interprofessional Care
25
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
25
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
34
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
34